# Combined Replacement Therapy With Levothyroxine and Liothyronine in Thyroidectomized Patients

> **NCT03053115** · PHASE2,PHASE3 · COMPLETED · sponsor: **Azienda USL Modena** · enrollment: 160 (actual)

## Conditions studied

- Hypothyroidism

## Interventions

- **DRUG:** Liothyronine
- **DRUG:** Levothyroxin
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03053115
- **Lead sponsor:** Azienda USL Modena
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-14
- **Primary completion:** 2021-09-05
- **Final completion:** 2022-06-30
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2023-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03053115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03053115, "Combined Replacement Therapy With Levothyroxine and Liothyronine in Thyroidectomized Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03053115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*